ARTICLE | Company News
Sigma-Tau sales and marketing update
May 6, 2013 7:00 AM UTC
Sigma-Tau launched Cystaran cysteamine ophthalmic solution in the U.S. to treat corneal cystine crystal accumulation in patients with cystinosis, a rare genetic lysosomal storage disease. Cystaran, a...